MODERATOR
:
SPEAKER
(S):
France Noizat-Pirenne, MD, PhD, Medical Director and Scientific Director, Etablissement Franais du Sang, Ile de France
Clinical relevance of Rh variants detected by molecular typing in sickle cell disease,,,
Stella Chou, MD, Assistant Professor of Pediatrics, The Children's Hospital of Philadelphia
Use of molecular typing to guide transfusion therapy for sickle cell disease
Dr. Karen King, MD, Director of Hemapheresis and Transfusion Support; Assoc Dir of Transfusion Medicine, Johns Hopkins Medical Institutions
Sickle cell disease-specific characteristics of hemolytic transfusion reactions
Description
Disparities in red cell antigen expression between donors and recipients with sickle cell disease contribute to high rates of alloimmunization and hemolytic transfusion reactions in this population. In this session, international and national perspectives on the clinical relevance of Rh variants and molecular typing programs by blood collection and hospital services to improve care for people with sickle cell disease will be presented. Unique aspects of hemolytic transfusion reactions in sickle cell disease, such as hyperhemolysis, will also be discussed.
-
Describe strategies to incorporate molecular typing into transfusion therapy for sickle cell disease.
-
Identify the sickle cell disease-specific characteristics of hemolytic transfusion reactions.
-
Recognize the clinical relevance of Rh variants detected by molecular typing in sickle cell disease.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.